Evidence map›Paper›PMID 42615906›Full record

ReviewInfection and immunity2026

What goes around comes around: updates in the study of

Kathleen N Pierce, Rebecca Anderson, Megan Brose, Jessica McCormick-Ell, Carrie Mae Long

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kathleen N PierceLaboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, Montana, USA.ORCID 0009-0003-2448-1822
Rebecca AndersonDivision of Safety, Office of Research Services, National Institutes of Health, Hamilton, Montana, USA.
Megan BroseDivision of Safety, Office of Research Services, National Institutes of Health, Hamilton, Montana, USA.
Jessica McCormick-EllDivision of Safety, Office of Research Services, National Institutes of Health, Bethesda, Maryland, USA.
Carrie Mae LongLaboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, Montana, USA.ORCID 0000-0001-5030-975X

Funding

Coxiella burnetii immunobiology, host-pathogen modeling, and countermeasure development ZIAAI001331 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LONG, CARRIE MAE · 2020 to 2025
$6.5M
Intramural NIH HHS ZIA AI001331NIH NIAID DIR ZIAAI001331
6 · The paper itself

Abstract

Lipopolysaccharide (LPS) is a major outer membrane component of Gram-negative bacteria that can modulate host immune responses during infection. Extensive studies on the LPS of well-studied organisms, such as

Indexed as

Coxiella burnetiiLipopolysaccharidesQ FeverAnimalsHost-Pathogen InteractionsHumansLipopolysaccharidesbiosafetyBSL-3Coxiellagram-negative bacterialipopolysaccharideLPSpathogenesisQ feverselect agentvaccines

Identifiers

PMID42615906
PMCPMC13552124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.